Bioavailability of intramuscular rocuronium in infants and children

Anesthesiology

Volumn 87, Issue 5, 1997, Pages 1096-1005

  Reynolds, Lynne M ^b   Lau, Marie ^b   Brown, Ronald ^b   Luks, Andrew ^b   Sharma, Manohar ^b   Fisher, Dennis M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Anesthesia: pediatric; pharmacokinetics; Injection: intramuscular; intravenous; Muscle relaxants: rocuronium bromide; Pharmacokinetics: bioavailability; mixed effects modeling; NONMEM

Indexed keywords

HALOTHANE; HISTAMINE; MIDAZOLAM; NEOSTIGMINE; NITROUS OXIDE; ROCURONIUM;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELTOID MUSCLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; ERYTHEMA; GAS LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE TWITCH; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIMULATION; TACHYCARDIA;

ANDROSTANOLS; BIOLOGICAL AVAILABILITY; CHILD, PRESCHOOL; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; METABOLIC CLEARANCE RATE; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 0030785331     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199711000-00014     Document Type: Article

References (10)

1. Reynolds LM, Lau M, Brown R, Luks A, Fisher DM: Intramuscular rocuronium in infants and children. Dose-ranging and tracheal intubating conditions. ANESTHESIOLOGY 1996; 85:231-9
2. Hashimoto Y, Sheiner LB: Designs for population pharmacodynamics: value of pharmacokinetic data and population analysis. J Pharmacokin Biopharmaceut 1991; 19:333-53
3. Mason LJ, Betts EK: Leg lift and maximum inspiratory force, clinical signs of neuromuscular blockade reversal in neonates and infants. ANESTHESIOLOGY 1980; 52:441-2
4. Furuta T, Canfell PC, Castagnoli KP, Sharma ML, Miller RD: Quantitation of pancuronium, 3 desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection. J Chromatogr 1988; 427:41-53
5. Gibaldi M, Perrier D: Pharmacokinetics, 2nd ed. New York, Marcel Dekker, 1982, p 48
6. -1 of rocuronium in infants during nitrous oxide-halothane anaesthesia. Paediatric Anaesthesia 1994; 4:173-7
7. Woelfel SK, Brandom BW, Cook DR, Sarner JB: Effects of bolus administration of ORG-9426 in children during nitrous oxide-halothane anesthesia. ANESTHESIOLOGY 1992; 76:939-42
8. Sorooshian SS, Stafford MA, Eastwood NB, Boyd AH, Hull CJ, Wright PMC: Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients. ANESTHESIOLOGY 1996; 84:1083-91
9. Vuksanaj D, Fisher DM: Pharmacokinetics of rocuronium in children aged 4-11 years. ANESTHESIOLOGY 1995; 82:1104-10
10. Szenohradszky J, Fisher DM, Segredo V, Caldwell JE, Bragg P, Sharma ML, Gruenke LD, Miller RD: Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. ANESTHESIOLOGY 1992; 77:899-904